Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03151304
Title A Safety and Efficacy Study of Pracinostat and Azacitidine in Patients With High Risk Myelodysplastic Syndromes
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Helsinn Healthcare SA
Indications

myelodysplastic syndrome

Therapies

Azacitidine + Pracinostat

Azacitidine

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.